Chronic respiratory diseases (CRDs) are major non-communicable diseases (NCDs) that induce a significant burden. Asthma often occurs along the life cycle from early childhood, affecting 30 million children and adults under 45 years of age in Europe. Chronic obstructive pulmonary disease (COPD) has an estimated annual death rate of over 3 million people globally. The annual direct and indirect costs in the 28 European Union (EU) countries due to COPD or asthma are estimated at 48 billion euros and 34 billion euros respectively. Rhinitis occurs in over 100 million people in Europe, and indirect costs are enormous. Asthma is a common risk factor for COPD. CRDs impact ageing and should be prevented, recognised and managed across the life cycle to promote active and healthy ageing (AHA). There is an urgent need to act globally. European Innovation Partnerships (EIPs) aim to enhance EU competitiveness and tackle societal challenges through research and innovation. To tackle the potential of ageing in the EU, the European Commission, within its Innovation Union policy, launched the EIP on AHA (between the Directorate General for Health and Food Safety (DG Santé) and Directorate General for Communications Networks, Content and Technology (DG CONNECT)). The B3 Action Plan promotes integrated care models for chronic diseases, including the use of remote monitoring. The initiative AIRWAYS-ICPs (integrated care pathways for airway diseases) has been approved by the EIP on AHA as the model of chronic diseases of the B3 Action Plan. It is a Research Demonstration Project of the World Health Organization's Global Alliance against Chronic Respiratory Diseases (GARD). AIRWAYS-ICPs was initiated in 2013 by the WHO Collaborating Centre of Montpellier and the EIP on AHA Reference Site MACVIA-LR (Contre les MAladies Chroniques Pour un VIeillissement Actif en Languedoc-Roussillon, France) led by the Région Languedoc-Roussillon (France).

AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

Paggiaro P
Membro del Collaboration Group
;
2016

Abstract

Chronic respiratory diseases (CRDs) are major non-communicable diseases (NCDs) that induce a significant burden. Asthma often occurs along the life cycle from early childhood, affecting 30 million children and adults under 45 years of age in Europe. Chronic obstructive pulmonary disease (COPD) has an estimated annual death rate of over 3 million people globally. The annual direct and indirect costs in the 28 European Union (EU) countries due to COPD or asthma are estimated at 48 billion euros and 34 billion euros respectively. Rhinitis occurs in over 100 million people in Europe, and indirect costs are enormous. Asthma is a common risk factor for COPD. CRDs impact ageing and should be prevented, recognised and managed across the life cycle to promote active and healthy ageing (AHA). There is an urgent need to act globally. European Innovation Partnerships (EIPs) aim to enhance EU competitiveness and tackle societal challenges through research and innovation. To tackle the potential of ageing in the EU, the European Commission, within its Innovation Union policy, launched the EIP on AHA (between the Directorate General for Health and Food Safety (DG Santé) and Directorate General for Communications Networks, Content and Technology (DG CONNECT)). The B3 Action Plan promotes integrated care models for chronic diseases, including the use of remote monitoring. The initiative AIRWAYS-ICPs (integrated care pathways for airway diseases) has been approved by the EIP on AHA as the model of chronic diseases of the B3 Action Plan. It is a Research Demonstration Project of the World Health Organization's Global Alliance against Chronic Respiratory Diseases (GARD). AIRWAYS-ICPs was initiated in 2013 by the WHO Collaborating Centre of Montpellier and the EIP on AHA Reference Site MACVIA-LR (Contre les MAladies Chroniques Pour un VIeillissement Actif en Languedoc-Roussillon, France) led by the Région Languedoc-Roussillon (France).
Bousquet, J; Barbara, C; Bateman, E; Bel, E; Bewick, M; Chavannes, Nh; Cruz, Aa; Haahtela, T; Hellings, Pw; Khaltaev, N; Carlsen, Kl; Muraro, A; Robalo Cordeiro, C; Rosado-Pinto, J; Samolinski, B; Strandberg, T; Valiulis, A; Yorgancioglu, A; Zuberbier, T; Adcock, I; Addis, A; Agachei, ; Agusti, A; Alonso, A; Annesi Maesano, I; Anto, Jm; Bachert, C; Baena-Cagnani, C; Bai, C; Baigenzhin, A; Barnes, Pj; Beck, L; Bedbrook, A; Benezet, O; Bennoor, Ks; Benson, M; Bernabeu-Wittel, M; Bindslev Jensen, C; Blain, H; Blasi, F; Bonini, M; Bonini, S; Boulet, Lp; Bourdin, A; Bourret, R; Bousquet, Pj; Brightling, Ce; Briggs, A; Brozek, J; Buhl, R; Bush, A; Caimmi, D; Calderon, M; Calverley, P; Camargos, P; Camuzat, T; Canonica, Gw; Carlsen, Kh; Casale, Tb; Cazzola, M; Cepeda Sarabia, Am; Cesario, A; Chen, Yz; Chkhartishvili, E; Chiron, R; Chuchalin, A; Chung, Kf; Cox, L; Crooks, G; Crooks, Mg; Custovic, A; Dahl, R; Dahlen, Se; De Blay, F; Dedeu, T; Deleanu, D; Demoly, P; Devillier, P; Didier, A; Dinhxuan, At; Djukanovic, R; Dokic, D; Douagui, H; Dubakiene, R; Eglin, S; Elliot, F; Emuzyte, R; Fabbri, L; Fink-Wagner, A; Fletcher, M; Fokkens, Wj; Fonseca, J; Franco, A; Frith, P; Furber, A; Gaga, M; Gamkrelidze, A; Garcia Aymerich, J; González-Díaz, S; Gouzi, F; Garcés, J; Guzmán, Ma; Harrison, D; Hayot, M; Heaney, L; Heinrich, J; Hooper, J; Humbert, M; Hyland, M; Iaccarino, G; Jakovenko, D; Jardim, J; Jeandel, C; Jenkins, C; Johnston, Sl; Jonquet, O; Joos, G; Jung, Ks; Kalayci, O; Karunanithi, S; Keil, T; Kolek, V; Kowalski, M; Kull, I; Kuna, P; Kvedariene, V; Lel, T; Louis, R; Macnee, W; Mair, A; Manning, P; Manuel Keenoy, Me; Majer, I; Masjedi, Mr; Melén, E; Melo Gomes, E; Menzies-Gow, A; Mercier, G; Mercier, J; Michel, Jp; Miculinic, N; Mihaltan, F; Milenkovic, B; Molimard, M; Momasi, ; Montilla-Santana, A; Morais Almeida, M; Morgan, M; N’Diaye, M; Nafti, S; Nekam Neou, A; Nicod, L; O’Hehir, R; Ohta, K; Paggiaro, P; Palkonen, S; Palmer, S; Papadopoulos, Ng; Papi, A; Passalacqua, G; Pavord, I; Pedersen, S; Pigearias, B; Plavec, D; Postma, Ds; Price, D; Rabe, Kf; Radier Pontal, F; Redon, J; Rennard, S; Roberts, J; Robine, Jm; Roca, J; Roche, N; Rodenas, F; Roggeri, A; Rolland, C; Ryan, D; Sanchez-Borges, M; Schünemann, Hj; Sheikh, A; Shields, M; Siafakas, N; Sibille, Y; Similowski, T; Small, I; Sola-Morales, O; Sooronbaev, T; Stelmach, R; Sterk, Pj; Stiris, T; Sud, P; Tellier, V; To, T; Todo Bom, A; Triggiani, M; Valenta, R; Valero, Al; Valovirtae, ; Vandenplas, O; Van Ganse, E; Vasankari, T; Vestbo, J; Vezzani, G; Viegi, G; Visier, L; Vogelmeier, C; Vontetsianos, T; Wagstaff, R; Wallaert, B; Wahn, U; Whalley, B; Wickman, M; Williams, D; Wilson, N; Yawn, Bp; Yiallouros, P; Yusuf, O; Zar, Hj; Zhong, N; Zidarn, M.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/898042
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact